1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Lung Inflammation: new trials by email Literature Review of Lung Inflammation trials Research Report on Lung Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treat COVID-19 Patients With Regadenoson Regadenoson, Placebo Control - COVID-19, Lung Inflammation | Phase 1 / Phase 2 | Completed | University of Maryland, Baltimore | 5 | 2021-05-06 | 2025-03-20 |
| Treatment of ARDS With Instilled T3 Liothyronine Sodium (T3+0.9% sodium chloride) modified formulation specifically for airway instillation., Non-intervention - ARDS, Human, Lung, Wet | Phase 2 | Active not recruiting | University of Minnesota | 68 | 2020-03-30 | 2026-04-07 |
Pneumonia (2) · COVID-19 (1) · Pulmonary Edema (1) · Respiratory Distress Syndrome (1) · Thyroid Diseases (1)
Infections (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Endocrine System Diseases (1) · Nidovirales Infections (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiration Disorders (1) · Virus Diseases (1)
Sodium Chloride (1) · Triiodothyronine (1) · regadenoson (1)
University of Maryland, Baltimore (1) · University of Minnesota (1)
United States (2)
Christine L Lau, MD, MBA (1) · David H Ingbar, MD (1) · Ronald A Reikoff, MD (1) · Timothy P Rich, MD (1)